Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1

Abstract

We have previously reported that astrocyte elevated gene-1 (AEG-1) was upregulated in human breast cancer. However, the biological function of AEG-1 in the development and progression of breast cancer remains to be clarified. In this study, we examined the effect of AEG-1 on cell proliferation and found that AEG-1 upregulation was significantly linked to increased Ki67 (P<0.001). Ectopic expression of AEG-1 in MCF-7 and MDA-MB-435 breast cancer cells dramatically enhanced cell proliferation and their ability of anchorage-independent growth, whereas silencing endogenous AEG-1 with shRNAs inhibited cell proliferation and colony-forming ability of the cells on soft agar. Furthermore, these proliferative effects were significantly associated with decreases of p27Kip1 and p21Cip1 two key cell-cycle inhibitors. Moreover, we further demonstrated that AEG-1 could downregulate the transcriptional activity of FOXO1 by inducing its phosphorylation through the PI3K/Akt signaling pathway. These observations were further confirmed in clinical human primary breast cancer specimens, in which high-level expression of AEG-1 was inversely correlated with the expression of FOXO1. Taken together, our results provide the first demonstration of a novel mechanism by which AEG-1 induces proliferation of breast cancer cell, and our findings suggest that AEG-1 might play an important role in tumorigenesis of breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Arden KC . (2007). FoxOs in tumor suppression and stem cell maintenance. Cell 128: 235–237.

    Article  CAS  Google Scholar 

  • Ash SC, Yang DQ, Britt DE . (2008). LYRIC/AEG-1 overexpression modulates BCCIPalpha protein levels in prostate tumor cells. Biochem Biophys Res Commun 371: 333–338.

    Article  CAS  Google Scholar 

  • Brown DM, Ruoslahti E . (2004). Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5: 365–374.

    Article  CAS  Google Scholar 

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo J, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857–868.

    Article  CAS  Google Scholar 

  • Cardozo T, Pagano M . (2004). The SCF ubiquitin ligase: insights into a molecular mechanism. Nat Rev Mol Cell Biol 5: 739–753.

    Article  CAS  Google Scholar 

  • Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW et al. (2000). Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27 (KIP1). Mol Cell Biol 20: 9138–9148.

    Article  CAS  Google Scholar 

  • Doerfler W, Hohlweg U, Müller K, Remus R, Heller H, Hertz J . (2001). Foreign DNA integration perturbations of the genome—oncogenesis. Ann NY Acad Sci 945: 276–288.

    Article  CAS  Google Scholar 

  • Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX et al. (2006). FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res 66: 6998–7006.

    Article  CAS  Google Scholar 

  • Emdad L, Sarkar D, Su ZZ, Lee SG, Kang DC, Bruce JN et al (2007). Astrocyte elevated gene-1: recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 114: 155–170.

    Article  CAS  Google Scholar 

  • Emdad L, Sarkar D, Su ZZ, Randolph A, Boukerche H, Valerie K et al. (2006). Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res 66: 1509–1516.

    Article  CAS  Google Scholar 

  • Frescas D, Pagano M . (2008). Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8: 438–449.

    Article  CAS  Google Scholar 

  • Greene FL, Page DL, Fleming ID . (2002). Breast Cancer in AJCC Cancer Staging Handbook. TNM Classification of Malignant Tumors, 6th edn. Springer Verlag: New York. pp 255–281.

    Google Scholar 

  • Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen J et al. (2005). Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Pros Natl Acad Sci USA 102: 1649–1654.

    Article  CAS  Google Scholar 

  • Kang DC, Su ZZ, Sarkar D, Emdad L, Volsky DJ, Fisher PB . (2005). Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353: 8–15.

    Article  CAS  Google Scholar 

  • Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y et al. (2007). Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26: 7647–7655.

    Article  CAS  Google Scholar 

  • Lee SG, Su ZZ, Emdad L, Sarkar D, Fisher PB . (2006). Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Pros Natl Acad Sci USA 103: 17390–17395.

    Article  CAS  Google Scholar 

  • Lee SG, Su ZZ, Emdad L, Sarkar D, Franke TF, Fisher PB . (2008). Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27: 1114–1121.

    Article  CAS  Google Scholar 

  • Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY et al. (2008). Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 3319–3326.

    Article  CAS  Google Scholar 

  • Liu J, Yuan Y, Huan J, Shen Z . (2001). Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. Oncogene 20: 336–345.

    Article  CAS  Google Scholar 

  • Meng X, Fan J, Shen Z . (2007). Roles of BCCIP in chromosome stability and cytokinesis. Oncogene 26: 6253–6260.

    Article  CAS  Google Scholar 

  • Meng X, Lu H, Shen Z . (2004). BCCIP functions through p53 to regulate the expression of p21Waf1/Cip1. Cell Cycle 3: 1457–1462.

    Article  CAS  Google Scholar 

  • Nakamura N, Ramaswamy S, Vazquez F, Signoretti S, Loda M, Sellers WR . (2000). Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol Cell Biol 20: 8969–8982.

    Article  CAS  Google Scholar 

  • Rena G, Guo S, Cichy SC, Unterman TG, Cohen P . (1999). Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 274: 17179–17183.

    Article  CAS  Google Scholar 

  • Roeb W, Boyer A, Cavenee WK, Arden KC . (2007). PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. Pros Natl Acad Sci USA 104: 18085–18090.

    Article  CAS  Google Scholar 

  • Sarkar D, Park ES, Emdad L, Lee SG, Su ZZ, Fisher PB . (2008). Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 68: 1478–1484.

    Article  CAS  Google Scholar 

  • Seoane J, Le HV, Shen L, Anderson SA, Massague J . (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211–223.

    Article  CAS  Google Scholar 

  • Tang ED, Nuñez G, Barr FG, Guan KL . (1999). Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274: 16741–16746.

    Article  CAS  Google Scholar 

  • Trent RJ . (2006). Molecular Medicine, 3rd edn. Academic Press: St Louis, MO, USA. pp 93–96.

    Google Scholar 

  • Ward EC, Hoekstra AV, Blok LJ, Hanifi-Moghaddam P, Lurain JR, Singh DK et al. (2008). The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Endocrinology 149: 1942–1950.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants from the Ministry of Science and Technology of China (Grant (973)2005CB724605); the Foundation of Ministry of Science and Technology of China (No. 30670803, 30770836, 30771110, 30870963, 30831160517, 30872930); Program for New Century Excellent Talents in University (Grant No. NCET-07-0877); the Science and Technology Department of Guangdong Province, China (No. 07001503, 8251008901000006, 2008A030201006); Foundation of Ministry of Education (No. (2008)890 and No. 200805580047); the Science and Technology Department of Guangdong Province, Zhuhai City (PC20071076); Guangdong Provincial Natural Science Foundation (Grant 2006Z3-E4081) and a key grant from the 985-II project.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Li.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, J., Yang, L., Song, L. et al. Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1. Oncogene 28, 3188–3196 (2009). https://doi.org/10.1038/onc.2009.171

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.171

Keywords

This article is cited by

Search

Quick links